Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 EUR | -1.27% | -.--% | -8.24% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.24% | 354M | |
+38.92% | 731B | |
+32.47% | 586B | |
-7.67% | 348B | |
+15.72% | 319B | |
-0.21% | 273B | |
+13.70% | 235B | |
-6.79% | 203B | |
+7.47% | 202B | |
+3.12% | 159B |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Hyloris Pharmaceuticals Wins US FDA's Orphan Drug Designation for Leukemia Treatment